Achieving Broad Participation in Meaningful Clinical Research at the Point of CareRegister
Contact InformationLuke Durocher
Founded in 2021, The Coalition for Advancing Clinical Trials at the Point of Care (ACT@POC™) aims to promote quality clinical research evidence in real time to better evaluate treatments and therapeutics. The Coalition looks to engage a broader, more diverse group of patients and providers and develop digital health tools that make clinical trials simpler to run and more accessible to patients.
The objective of this multi-stakeholder coalition aims to drive implementation of large-scale clinical trials at the community level—in the doctor’s offices and care facilities where most of the U.S. population receives care.
The costs of clinical trials are high and are continuing to rise, resulting in slow innovation in many areas and limiting the types of sites that can run clinical trials. ACT@POC is convening a public meeting on June 14, 2022 at 2:00pm ET to explore the barriers to broader clinical trial participation by clinicians at the point of care as well as new opportunities to overcome these barriers. Enabling more meaningful clinical research at the point of care will help close major gaps in clinical trial evidence generation, improve patient care, and move us towards a learning health system. Click here for more information and to register for Achieving Broad Participation in Meaningful Clinical Research at the Point of Care.
Duke-Margolis Planning Team
Policy Research Associate
Assistant Research Director
Senior Research Director, Biomedical Innovation
Faculty Director of the Duke-Margolis Postdoctoral Associates & Affiliated Fellows Program
Adjunct Associate Professor
Senior Team Member
Margolis Core Faculty